Titre : Crédit et recouvrement patient

Crédit et recouvrement patient : Questions médicales fréquentes

Termes MeSH sélectionnés :

Drug Overdose

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment évaluer la solvabilité d'un patient ?

La solvabilité peut être évaluée par des antécédents de paiement et des scores de crédit.
Évaluation du crédit Antécédents médicaux
#2

Quels outils utilisent les établissements pour le recouvrement ?

Les établissements utilisent des logiciels de gestion de créances et des services de recouvrement.
Gestion des créances Services de recouvrement

Symptômes 2

#1

Quels signes indiquent des problèmes de paiement ?

Des retards fréquents dans les paiements ou des refus de paiement peuvent être des signes.
Retard de paiement Refus de paiement
#2

Comment les patients réagissent-ils au stress financier ?

Le stress financier peut entraîner de l'anxiété, de la dépression et des problèmes de santé.
Stress financier Santé mentale

Prévention 2

#1

Comment prévenir les problèmes de recouvrement ?

Une communication claire sur les coûts et les options de paiement peut aider à prévenir les problèmes.
Communication financière Prévention des créances
#2

Quel rôle joue l'éducation financière des patients ?

L'éducation financière aide les patients à mieux gérer leurs dépenses de santé et à éviter les dettes.
Éducation financière Gestion des dépenses

Traitements 2

#1

Quelles options de paiement sont offertes aux patients ?

Les options incluent des plans de paiement échelonnés et des réductions pour paiement anticipé.
Plans de paiement Réductions financières
#2

Comment gérer les créances irrécouvrables ?

Les créances irrécouvrables peuvent être transférées à des agences de recouvrement spécialisées.
Créances irrécouvrables Agences de recouvrement

Complications 2

#1

Quelles complications peuvent survenir en cas de non-paiement ?

Le non-paiement peut entraîner des restrictions de soins et des impacts sur le crédit du patient.
Non-paiement Impact sur le crédit
#2

Comment le non-paiement affecte-t-il la relation patient-fournisseur ?

Le non-paiement peut créer des tensions et nuire à la confiance entre le patient et le fournisseur.
Relation patient-fournisseur Confiance

Facteurs de risque 2

#1

Quels facteurs augmentent le risque de non-paiement ?

Les facteurs incluent le faible revenu, le manque d'assurance et des antécédents de dettes.
Faible revenu Antécédents de dettes
#2

Comment l'âge influence-t-il le recouvrement ?

Les personnes âgées peuvent avoir des difficultés financières accrues, augmentant le risque de non-paiement.
Personnes âgées Difficultés financières
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Crédit et recouvrement patient : Questions médicales les plus fréquentes", "headline": "Crédit et recouvrement patient : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Crédit et recouvrement patient : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-06", "dateModified": "2025-04-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Crédit et recouvrement patient" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Comptabilité", "url": "https://questionsmedicales.fr/mesh/D000066", "about": { "@type": "MedicalCondition", "name": "Comptabilité", "code": { "@type": "MedicalCode", "code": "D000066", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.219.463.030" } } }, "about": { "@type": "MedicalCondition", "name": "Crédit et recouvrement patient", "alternateName": "Patient Credit and Collection", "code": { "@type": "MedicalCode", "code": "D010350", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Fernando Alfonso", "url": "https://questionsmedicales.fr/author/Fernando%20Alfonso", "affiliation": { "@type": "Organization", "name": "Chairman Editors' Network. Electronic address: falf@hotmail.com." } }, { "@type": "Person", "name": "Parounak Zelveian", "url": "https://questionsmedicales.fr/author/Parounak%20Zelveian", "affiliation": { "@type": "Organization", "name": "Editor in Chief Armenian Journal of Cardiology." } }, { "@type": "Person", "name": "Michael Aschermann", "url": "https://questionsmedicales.fr/author/Michael%20Aschermann", "affiliation": { "@type": "Organization", "name": "Editor in Chief Cor et Vasa." } }, { "@type": "Person", "name": "Alfonso Buendia Hernandez", "url": "https://questionsmedicales.fr/author/Alfonso%20Buendia%20Hernandez", "affiliation": { "@type": "Organization", "name": "Editor in Chief Archivos de Cardiologia de Mexico." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Hemoperfusion in Poisoning and Drug Overdose.", "datePublished": "2023-06-13", "url": "https://questionsmedicales.fr/article/37311422", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000526730" } }, { "@type": "ScholarlyArticle", "name": "Educational Attainment and US Drug Overdose Deaths.", "datePublished": "2023-10-06", "url": "https://questionsmedicales.fr/article/37801307", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamahealthforum.2023.3274" } }, { "@type": "ScholarlyArticle", "name": "Psychological distress and the risk of drug overdose death.", "datePublished": "2022-08-31", "url": "https://questionsmedicales.fr/article/36057284", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jad.2022.08.115" } }, { "@type": "ScholarlyArticle", "name": "Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon.", "datePublished": "2024-09-03", "url": "https://questionsmedicales.fr/article/39235814", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2024.31612" } }, { "@type": "ScholarlyArticle", "name": "Association of drug overdoses and user characteristics of Canada's national mobile/virtual overdose response hotline: the National Overdose Response Service (NORS).", "datePublished": "2023-09-27", "url": "https://questionsmedicales.fr/article/37752527", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-023-16751-z" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Organisations et économie des soins de santé", "item": "https://questionsmedicales.fr/mesh/D004472" }, { "@type": "ListItem", "position": 3, "name": "Économie", "item": "https://questionsmedicales.fr/mesh/D004467" }, { "@type": "ListItem", "position": 4, "name": "Gestion financière", "item": "https://questionsmedicales.fr/mesh/D005376" }, { "@type": "ListItem", "position": 5, "name": "Comptabilité", "item": "https://questionsmedicales.fr/mesh/D000066" }, { "@type": "ListItem", "position": 6, "name": "Crédit et recouvrement patient", "item": "https://questionsmedicales.fr/mesh/D010350" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Crédit et recouvrement patient - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Crédit et recouvrement patient", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Crédit et recouvrement patient", "description": "Comment évaluer la solvabilité d'un patient ?\nQuels outils utilisent les établissements pour le recouvrement ?", "url": "https://questionsmedicales.fr/mesh/D010350?mesh_terms=Drug+Overdose#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Crédit et recouvrement patient", "description": "Quels signes indiquent des problèmes de paiement ?\nComment les patients réagissent-ils au stress financier ?", "url": "https://questionsmedicales.fr/mesh/D010350?mesh_terms=Drug+Overdose#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Crédit et recouvrement patient", "description": "Comment prévenir les problèmes de recouvrement ?\nQuel rôle joue l'éducation financière des patients ?", "url": "https://questionsmedicales.fr/mesh/D010350?mesh_terms=Drug+Overdose#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Crédit et recouvrement patient", "description": "Quelles options de paiement sont offertes aux patients ?\nComment gérer les créances irrécouvrables ?", "url": "https://questionsmedicales.fr/mesh/D010350?mesh_terms=Drug+Overdose#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Crédit et recouvrement patient", "description": "Quelles complications peuvent survenir en cas de non-paiement ?\nComment le non-paiement affecte-t-il la relation patient-fournisseur ?", "url": "https://questionsmedicales.fr/mesh/D010350?mesh_terms=Drug+Overdose#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Crédit et recouvrement patient", "description": "Quels facteurs augmentent le risque de non-paiement ?\nComment l'âge influence-t-il le recouvrement ?", "url": "https://questionsmedicales.fr/mesh/D010350?mesh_terms=Drug+Overdose#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la solvabilité d'un patient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La solvabilité peut être évaluée par des antécédents de paiement et des scores de crédit." } }, { "@type": "Question", "name": "Quels outils utilisent les établissements pour le recouvrement ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les établissements utilisent des logiciels de gestion de créances et des services de recouvrement." } }, { "@type": "Question", "name": "Quels signes indiquent des problèmes de paiement ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des retards fréquents dans les paiements ou des refus de paiement peuvent être des signes." } }, { "@type": "Question", "name": "Comment les patients réagissent-ils au stress financier ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Le stress financier peut entraîner de l'anxiété, de la dépression et des problèmes de santé." } }, { "@type": "Question", "name": "Comment prévenir les problèmes de recouvrement ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une communication claire sur les coûts et les options de paiement peut aider à prévenir les problèmes." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation financière des patients ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation financière aide les patients à mieux gérer leurs dépenses de santé et à éviter les dettes." } }, { "@type": "Question", "name": "Quelles options de paiement sont offertes aux patients ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les options incluent des plans de paiement échelonnés et des réductions pour paiement anticipé." } }, { "@type": "Question", "name": "Comment gérer les créances irrécouvrables ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les créances irrécouvrables peuvent être transférées à des agences de recouvrement spécialisées." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir en cas de non-paiement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Le non-paiement peut entraîner des restrictions de soins et des impacts sur le crédit du patient." } }, { "@type": "Question", "name": "Comment le non-paiement affecte-t-il la relation patient-fournisseur ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Le non-paiement peut créer des tensions et nuire à la confiance entre le patient et le fournisseur." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de non-paiement ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le faible revenu, le manque d'assurance et des antécédents de dettes." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le recouvrement ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées peuvent avoir des difficultés financières accrues, augmentant le risque de non-paiement." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 02/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

None None

3 publications dans cette catégorie

Publications dans "Crédit et recouvrement patient" :

Fernando Alfonso

3 publications dans cette catégorie

Affiliations :
  • Chairman Editors' Network. Electronic address: falf@hotmail.com.
Publications dans "Crédit et recouvrement patient" :

Parounak Zelveian

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Armenian Journal of Cardiology.
Publications dans "Crédit et recouvrement patient" :

Michael Aschermann

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Cor et Vasa.
Publications dans "Crédit et recouvrement patient" :

Alfonso Buendia Hernandez

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Archivos de Cardiologia de Mexico.
Publications dans "Crédit et recouvrement patient" :

Ariel Cohen

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Archives of Cardiovascular Diseases.
Publications dans "Crédit et recouvrement patient" :

Sebija Izetbegovic

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Medicinski Zurnal.
Publications dans "Crédit et recouvrement patient" :

Anton Doubell

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief SA Heart.
Publications dans "Crédit et recouvrement patient" :

Dario Echeverri

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Revista Colombiana de Cardiologia.
Publications dans "Crédit et recouvrement patient" :

Nuray Enç

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Kardiyovaskuler Hemsirelik Dergisi.
Publications dans "Crédit et recouvrement patient" :

Ignacio Ferreira-González

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Revista Española de Cardiología.
Publications dans "Crédit et recouvrement patient" :

Anetta Undas

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Kardiologia Polska.
Publications dans "Crédit et recouvrement patient" :

Ulrike Fortmüller

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Cardio News.
Publications dans "Crédit et recouvrement patient" :

Plamen Gatzov

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Bulgarian Journal of Cardiology.
Publications dans "Crédit et recouvrement patient" :

Carmen Ginghina

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Romanian Journal of Cardiology.
Publications dans "Crédit et recouvrement patient" :

Lino Goncalves

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Revista Portuguesa de Cardiologia.
Publications dans "Crédit et recouvrement patient" :

Mahmoud Hassanein

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief The Egyptian Heart Journal.
Publications dans "Crédit et recouvrement patient" :

Gerd Heusch

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Basic Research in Cardiology.
Publications dans "Crédit et recouvrement patient" :

Kurt Huber

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Austrian Journal fo Cardiology.
Publications dans "Crédit et recouvrement patient" :

Robert Hatala

3 publications dans cette catégorie

Affiliations :
  • Editor in Chief Cardiology Letters.
Publications dans "Crédit et recouvrement patient" :

Sources (10000 au total)

Educational Attainment and US Drug Overdose Deaths.

Educational attainment in the US is associated with life expectancy. As the opioid crisis worsens, it is critical to understand how overdose death rate trends evolve across education groups.... To investigate the association between educational attainment and overdose death rates, with emphasis on trends during the COVID-19 pandemic.... This cross-sectional study used National Vital Statistics System Mortality Multiple Cause-of-Death data describing overdose death rates in the US by educational attainment from January 1, 2000, to Dec... Educational attainment, categorized as no high school (HS) diploma, HS diploma (or General Educational Development) but no college, some college but no bachelor's degree, and bachelor's degree or more... The main outcomes were rates of all overdose deaths, overdose deaths involving opioids, and overdose deaths involving synthetic opioids.... Of 912 057 overdose deaths with education information from 2000 to 2021 (mean [SD] age at death, 44.9 [12.3] years; 64.1% male), there were 625 400 deaths (68.6%) among individuals with no college edu... In this cross-sectional study, lower educational attainment was found to be associated with higher growth in overdose deaths. As the opioid crisis has transitioned to fentanyl and polysubstance use, o...

Psychological distress and the risk of drug overdose death.

Previous research has shown an association between psychological distress and overdose death among specific populations. However, few studies have examined this relationship in a large US population-b... Data from the 2010-2018 NHIS were linked to mortality data from the National Death Index through 2019. Psychological distress was measured using the Kessler 6 scale. Drug overdose deaths were examined... The study population included 272,561 adults. Adjusting for demographic covariates and using no psychological distress as the reference, distress level was positively associated with the risk of overd... Limited substance use information prevented adjustment for this potentially important covariate.... Adults with psychological distress were at greater risk of drug overdose death, relative to those without psychological distress. Adults with psychological distress were also at increased risk of deat...

Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon.

With the implementation of Measure 110 (M110) in 2021, Oregon became the first US state to decriminalize small amounts of any drug for personal use. To date, no analysis of the association of this law... To evaluate whether the decriminalization of drug possession in Oregon was associated with changes in fatal drug overdose rates after accounting for the rapid spread of fentanyl in Oregon's unregulate... In this cohort study, the association between fatal overdose and enactment of M110 was analyzed using a matrix completion synthetic control method. The control group consisted of the 48 US states and ... Measure 110 took effect in Oregon on February 1, 2021.... The primary outcome assessed was fatal drug overdose rates per half-year. A changepoint analysis also determined when each state experienced a rapid escalation of fentanyl in its unregulated drug mark... In this analysis, rapid spread of fentanyl in Oregon's unregulated drug supply occurred in the first half of 2021, contemporaneous with enactment of M110. A positive crude association was found betwee... In this cohort study of fatal drug overdose and the spread of fentanyl through Oregon's unregulated drug market, no association between M110 and fatal overdose rates was observed. Future evaluations o...

Association of drug overdoses and user characteristics of Canada's national mobile/virtual overdose response hotline: the National Overdose Response Service (NORS).

Several novel overdose response technology interventions, also known as mobile overdose response services (MORS), have emerged as adjunct measures to reduce the harms associated with the drug poisonin... A retrospective analysis was conducted using NORS call logs from December 2020 to April 2023 imputed by operators. A variety of variables were examined including demographics, substance use and route,... Of the 6528 completed calls on the line, 3994 (61.2%) were for supervised drug consumption, 1703 (26.1%) were for mental health support, 354 (5.42%) were for harm reduction education or resources, and... NORS presents a complimentary opportunity to access harm reduction services for individuals that prefer to use alone or face barriers to accessing in-person supervised consumption services especially ...

Estimating Drug Involvement in Fatal Overdoses With Incomplete Information.

Death certificates provide incomplete information on the specific drug categories involved in fatal overdoses. The accuracy of previously developed corrections for this and modifications to them was e... Data were obtained for the universe of 932,364 drug overdoses in the U.S. between 1999 and 2020, including 769,982 (82.6%) with a drug classification and 162,382 (17.4%) without, from the National Cen... Previous regression-based corrections that controlled for decedent characteristics can be improved upon by adding state-fixed effects as covariates. Once this is done, supplementary controls for count... Failing to correct for incomplete information on death certificates leads to inaccurate counts of deaths from specific categories of drugs, such as opioids. However, relatively simple corrections are ...

Estimating the uncertain effect of the COVID pandemic on drug overdoses.

U.S. drug-related overdose deaths and Emergency Department (ED) visits rose in 2020 and again in 2021. Many academic studies and the news media attributed this rise primarily to increased drug use res... We use national data from the Centers for Disease Control and Prevention (CDC) on rolling 12-month drug-related deaths (2015-2021); CDC data on monthly ED visits (2019-September 2020) for EDs in 42 st... Mortality. National overdose mortality increased from 21/100,000 in 2019 to 26/100,000 in 2020 and 30/100,000 in 2021. The rise in mortality began in mid-to-late half of 2019, and the 2020 increase is... The reasons for rising overdose mortality in 2020 and 2021 cannot be definitely determined. We lack a control group and thus cannot assess causation. However, the observed increases can be largely exp...

Years of life lost to drug overdose in the Latinx community during the most recent wave of overdose deaths.

This study estimated years of life lost (YLL) among US Latinx individuals during the most recent wave of drug overdose deaths.... A serial cross-sectional study of YLL (life expectancy minus age at death) from death certificate records of Latinx individuals who died from drug overdoses from 2015 to mid-2022.... Over the study period, 58,209 Latinx individuals aged 15-64 years died from drug overdoses resulting in 2,266,784 YLL. Age-group YLL differences remained stable, but gender YLL trajectories diverged.... This study extends our understanding of the immense loss to Latinx communities from preventable drug deaths....